Chiara Tramontano (CT) is a Ph.D. student in Pharmaceutical Sciences at the Institute of Applied Sciences and Intelligent Systems (ISASI) of the National Research Council of Naples. She is part of the NanoBioSYstems Group (NBSY), a multidisciplinary research team composed of physicists, chemists, and biotechnologists. Her research interests lie in the synthesis, surface functionalization, and characterization of advanced natural or manufactured organic porous nanoparticles (NPs) for drug delivery and theranostic applications. She focuses on several surface chemistry approaches to develop NP-based formulations for delivering anticancer small molecules with high first-pass effect and poor water solubility. She is currently involved in the design of antibody-labelled NPs for the site-specific delivery of Galunisertib to colorectal cancer cells via an active targeting strategy. Her side activities focus on the bioconjugation of proteins, antibodies, DNA and other molecules onto several materials, such as mesoporous silica/silicon NPs and gold NPs, for the diagnosis and treatment of human diseases.